Recombinant human growth hormone exacerbates chronic puromycin aminonucleoside nephropathy in rats (Q42287547)

19 October 2017

Recombinant human growth hormone exacerbates chronic puromycin aminonucleoside nephropathy in rats (English)

1 reference

19 October 2017

1 reference

Trachtman H

1

1 reference

19 October 2017

Futterweit S

2

1 reference

19 October 2017

Schwob N

3

1 reference

19 October 2017

Maesaka J

4

1 reference

19 October 2017

Valderrama E

5

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 December 1993

1 reference

19 October 2017

1 reference

19 October 2017

44

1 reference

19 October 2017

1281-1288

1 reference

19 October 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1993.380

19 October 2017

0 references

cites work

Growth in children with renal insufficiency.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Chronic renal failure and growth

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Improvement of growth and food utilization by human recombinant growth hormone in uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Accelerated growth after recombinant human growth hormone treatment of children with chronic renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Treatment of short stature in renal disease with recombinant human growth hormone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Glomerulosclerosis in mice transgenic for growth hormone. Increased mesangial extracellular matrix is correlated with kidney mRNA levels

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Role of growth hormone in the development of experimental renal scarring

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Effects of prolonged growth hormone administration in rats with chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Somatic growth in corticosteroid-treated rats with passive Heymann nephritis--effects of recombinant human growth hormone on growth impairment

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Mesangial function and glomerular sclerosis in rats with aminonucleoside nephrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

A role for oxygen free radicals in aminonucleoside nephrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Stimulating growth in uremic children

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

How safe is the treatment of uraemic children with recombinant human growth hormone?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Recombinant human growth hormone treatment of children with chronic renal failure: long-term (1- to 3-year) outcome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Measurement of renal function in chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Accelerated growth rates in children treated with growth hormone after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.380

7 January 2021

Identifiers

DOI

10.1038/KI.1993.380

1 reference

release_qmky43jszfblveweazjauhkvtu

19 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qmky43jszfblveweazjauhkvtu

24 November 2022

mapped directly with Wikidata item

1 reference